Skip to product content

ACTIVE PHARMACEUTICAL INGREDIENT

Montmorillonite API

Research Montmorillonite API through China CDE registrations. Compare reported companies, packaging and review statuses, preview source records, then subscribe to search and export the complete available dataset.

Complete data requires an active subscription. Already subscribed? Sign in to access your data.

This Montmorillonite profile covers records named 蒙脱石. CAS 1318-93-0 identifies the reference mineral; the registry does not independently verify the CAS or grade of each material. Bentonite filings are excluded.

Montmorillonite registration data overview

The supplied snapshots contain 18 Montmorillonite CDE registrations: 16 with A status and 2 with I status. No subjects containing Montmorillonite or Diosmectite were found in the FDA Q2 2026 workbook.

These are dated, name-selected records. The FDA result applies only to those search terms in the June 30, 2026 snapshot, not to every possible filing name or later list. Registration counts are not counts of qualified or available suppliers.

Personal API data subscription

$19.00 per month

$149.00 per year

Billed $149.00 every year

This Montmorillonite profile: 18 CDE registrations. No Montmorillonite or Diosmectite subjects were found in the supplied FDA Q2 2026 snapshot.

Subscription benefits and CSV samples
  • Complete available registry records
  • Search and status filters
  • Documented company-name correspondences
  • CSV exports with sources

One personal account can access subscription datasets currently available on APIRFQ. Coverage varies by product. This does not include quotations, supplier qualification or live monitoring.

CHINA REGULATORY RECORDS

Montmorillonite NMPA CDE registrations

Compare Montmorillonite registrations by number, reported company, product origin and review status. Open each sample to inspect its original Chinese fields, including packaging, addresses and source remarks.

18 Montmorillonite registration records · 17 distinct reported company fields

16Approved or qualifying prior approval (A)

2Technical review not passed or unlinked (I)

CDE A indicates an approved or qualifying reviewed registration through one of the regulator’s stated routes. I means technical review has not been passed or the material has not been linked to a formulation registration. These meanings differ from FDA active and inactive status. Neither the status nor a reported validity date verifies present supply or batch suitability.

Free previewShowing 3 sample records of 18.

  • 山东京卫制药有限公司Registration number Y20170000022Technical review not passed or unlinked (I)Record details
    Registration number
    Y20170000022
    Reported substance name
    蒙脱石
    Reported company names
    山东京卫制药有限公司
    Reported company addresses
    山东省泰安高新技术产业开发区创业大街中段
    Reported product origin
    Domestic (国产)
    Reported packaging
    每袋25kg
    Reported specification
    Not provided by source
    Record updated
    Not provided by source
    Joint review status
    Technical review not passed or unlinked (I)
    Reported validity date
    Not provided by source
    Source remarks
    CYHS0900886
  • 烟台瑞东科技发展有限公司Registration number Y20170000480Approved or qualifying prior approval (A)Record details
    Registration number
    Y20170000480
    Reported substance name
    蒙脱石
    Reported company names
    烟台瑞东科技发展有限公司
    Reported company addresses
    烟台市环海路88号
    Reported product origin
    Domestic (国产)
    Reported packaging
    30kg/桶
    Reported specification
    Not provided by source
    Record updated
    Not provided by source
    Joint review status
    Approved or qualifying prior approval (A)
    Reported validity date
    Not provided by source
    Source remarks
    CYHS1300696
  • 湖南华纳大药厂股份有限公司Registration number Y20170000501Approved or qualifying prior approval (A)Record details
    Registration number
    Y20170000501
    Reported substance name
    蒙脱石
    Reported company names
    湖南华纳大药厂股份有限公司
    Reported company addresses
    浏阳经济技术开发区健康大道南路5号
    Reported product origin
    Domestic (国产)
    Reported packaging
    10kg/桶,25kg/桶
    Reported specification
    Not provided by source
    Record updated
    2023-11-04
    Joint review status
    Approved or qualifying prior approval (A)
    Reported validity date
    2028-11-02
    Source remarks
    CYHS1300735

Free preview

More records available with a subscription: 15.

Inclusion criteria
  • Includes 18 records whose reported substance name is exactly 蒙脱石. Selection by name does not independently establish CAS 1318-93-0, mineral composition, pharmaceutical grade or a particular manufacturer specification for every registration.
  • All eleven source columns and the original CSV row order are retained. Blank cells and ---- remain as reported; the interface labels missing values as Not provided by source.
  • Semicolon-separated names and addresses, repeated parties, packaging units, dates and approval references are preserved. The order of names does not establish manufacturer, holder or agent roles. Distinct company fields are not a count of independently qualified manufacturers.

Montmorillonite identity and material scope

Montmorillonite is a clay mineral of the smectite group. EPA identifies Montmorillonite with CAS 1318-93-0. Its exchangeable cations and hydration can vary, so this profile does not assign a single molecular weight or a discrete-molecule drawing. The CDE records in this profile were selected by the reported name 蒙脱石, not by independently verified batch composition.

CAS number
1318-93-0
EPA: Montmorillonite

Reference Montmorillonite identity; not an independently confirmed CAS assignment for every registry entry.

CDE reported substance name
蒙脱石
NMPA CDE API registry snapshot
EPA substance identifier
DTXSID6051225
EPA: Montmorillonite
Composition
Hydrated aluminosilicate with variable interlayer cations
WHO: Bentonite, Kaolin and Selected Clay Minerals

A mineral identity does not establish the pharmaceutical specification of a supplied material.

Montmorillonite research resources

Use these original references to check Montmorillonite identity and interpret the registry information.

Montmorillonite API sourcing questions

What identity does this Montmorillonite API profile cover?

The reference identity is Montmorillonite, CAS 1318-93-0, a smectite-group clay mineral. The CDE dataset contains registrations reported as 蒙脱石. A matching name is a starting point for research, not proof of a particular mineral composition or pharmaceutical specification.

Is Montmorillonite the same material as bentonite?

Bentonite is a rock or industrial clay material composed mainly of Montmorillonite and potentially other minerals. A bentonite filing therefore does not establish a Montmorillonite API registration or an interchangeable pharmaceutical grade. Bentonite subjects are excluded from this profile.

Can diosmectite be treated as an interchangeable Montmorillonite grade?

Do not infer interchangeability from the names alone. ANSM’s French Pharmacopoeia denomination describes diosmectite as a natural hydrated aluminium-magnesium silicate in the dioctahedral smectite group, also identifying other constituents and a French deposit origin. That description does not verify the composition or specification of an individual Montmorillonite registration. Compare the applicable dossier and material specification.

Which Montmorillonite CDE records are included?

The October 5, 2026 snapshot contains 18 records named exactly 蒙脱石, with 16 A entries and 2 I entries. Original company fields, packaging, addresses, dates and remarks are retained. Multiple registrations or repeated names do not establish separate qualified Montmorillonite manufacturers.

What do A and I mean for Montmorillonite registrations?

CDE A can follow joint review with an approved formulation, transfer of qualifying prior approvals, or independent review of an API equivalent to one already marketed domestically. I means technical review has not been passed or the material has not been linked to a formulation registration. These Chinese review identifiers differ from FDA DMF activity status and do not establish current Montmorillonite supply.

Does the FDA result mean no Montmorillonite DMF exists?

No. The supplied FDA Q2 2026 workbook contains no SUBJECT values matching Montmorillonite or Diosmectite, searched case-insensitively across all types and statuses. This result is limited to those names and that snapshot. Filings under other terms or in later lists have not been ruled out. FDA also states that DMFs are neither approved nor disapproved.

What should a Montmorillonite buyer verify next?

Use the registration number to check the current official entry, then ask the relevant party to confirm its legal role, manufacturing site, material identity, specification and supporting quality documents for your intended market. Compare those documents with the Montmorillonite material being offered. Source-listed packaging and validity dates are reported fields, not verified availability or a commercial quotation.

What is included in the Montmorillonite data subscription?

Free visitors can inspect Montmorillonite sample records and source references. An active personal subscription provides the complete available CDE dataset, search, status filters and CSV export through the existing product tools. It does not provide a supplier quotation, qualification decision or access to confidential dossiers. No matching FDA records are included for this profile.

EPA: MontmorilloniteWHO: Bentonite, Kaolin and Selected Clay MineralsNMPA CDE API registry snapshotFDA DMF list: Q2 2026 snapshotANSM: Diosmectite scientific denominationChina API registration status explainedFDA: Drug Master Files

Data sources

Montmorillonite identity references and the two supplied registry snapshots have different scopes. Each source below identifies the evidence used for this profile.

EPA: Montmorillonite

Open source reference

U.S. Environmental Protection Agency

Reference identity for Montmorillonite, CAS 1318-93-0, and identifier DTXSID6051225.

View citation evidence

“1318-93-0”

U.S. Environmental Protection Agency

CAS number displayed in the EPA ChemExpo Montmorillonite entry.

WHO: Bentonite, Kaolin and Selected Clay Minerals

Open source reference

World Health Organization / International Programme on Chemical Safety

Section 2.2.1 explains the mineral terminology and variable composition relevant to this profile.

View citation evidence

“a clay mineral of the smectite group”

World Health Organization / International Programme on Chemical Safety

EHC 231, section 2.2.1, describes montmorillonite within the definition of bentonite.

ANSM: Diosmectite scientific denomination

Open source reference

Agence nationale de sécurité du médicament et des produits de santé

The French Pharmacopoeia 2002 entry defines diosmectite by mineral composition and deposit origin; it is not evidence of equivalence for any listed batch.

View citation evidence

“groupe des smectites dioctaédriques”

Agence nationale de sécurité du médicament et des produits de santé

Diosmectite entry, printed page 8 of the French Pharmacopoeia denomination list.

FDA DMF list: Q2 2026 snapshot

Open source reference

U.S. Food and Drug Administration

Montmorillonite and Diosmectite searches used the supplied Q2 workbook, sheet 2Q2026-EXCEL, with a June 30, 2026 cutoff. The official page may link to a later list.

View citation evidence

“SUBJECT”

U.S. Food and Drug Administration

Source workbook column searched for the two substance-name terms; no matching rows were found.

FDA: Drug Master Files

Open source reference

U.S. Food and Drug Administration

Explains the role of a DMF and the limits of interpreting a public listing.

View citation evidence

“Are neither approved nor disapproved.”

U.S. Food and Drug Administration

FDA statement on DMFs; an active DMF is not approval of a product or supplier.

NMPA CDE API registry snapshot

Open source reference

Center for Drug Evaluation, National Medical Products Administration

Montmorillonite registrations selected from the supplied October 5, 2026 full CSV export.

View citation evidence

“蒙脱石”

Center for Drug Evaluation, National Medical Products Administration

Exact reported substance name used to select the CDE records.

China API registration status explained

Open source reference

Liaoning Medical Products Administration

Official explanation of A and I identifiers and the three routes to A status.

View citation evidence

“未通过技术审评或尚未与制剂注册进行关联的标识为“I”。”

Liaoning Medical Products Administration

The regulator explains I as material that has not passed technical review or has not been linked to a formulation registration.

Continue your Montmorillonite API research

Use Montmorillonite registration numbers, reported names and status explanations to guide your sourcing review. Subscribe to search, filter and export the complete available CDE records after checking the free samples.

Complete data requires an active subscription. Already subscribed? Sign in to access your data.

Report a Montmorillonite data issue

Send APIRFQ the Montmorillonite page address, disputed registration number and supporting source so the reported data can be checked.

Contact data support